Champions Oncolog
(CSBR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 07-2009 | 04-2009 | 01-2009 | 10-2008 | 07-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,530 | 1,728 | 2,625 | 3,053 | 3,495 |
| Marketable Securities | N/A | 1,017 | 1,005 | N/A | N/A |
| Receivables | N/A | N/A | N/A | 77 | 6 |
| TOTAL | $2,472 | $3,870 | $4,082 | $3,325 | $3,668 |
| Non-Current Assets | |||||
| PPE Net | 102 | 81 | N/A | N/A | N/A |
| Intangibles | 669 | 669 | 928 | 898 | 904 |
| TOTAL | $771 | $750 | $928 | $898 | $904 |
| Total Assets | $3,243 | $4,620 | $5,010 | $4,224 | $4,572 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,401 | 1,414 | 696 | 308 | 189 |
| Accrued Expenses | 86 | 67 | N/A | N/A | N/A |
| TOTAL | $2,433 | $2,704 | $2,057 | $770 | $996 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 946 | 1,223 | 1,361 | 462 | 807 |
| Other Non-Current Liabilities | 250 | 0 | 0 | 0 | 0 |
| TOTAL | $250 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,683 | $2,704 | $2,057 | $770 | $996 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,723 | 2,717 | 2,781 | 2,772 | 2,772 |
| Common Shares | 34 | 34 | 33 | 33 | 33 |
| Retained earnings | -10,760 | -9,757 | -8,091 | -7,468 | -7,236 |
| Other shareholders' equity | -157 | -1 | -646 | -755 | -801 |
| TOTAL | $560 | $1,916 | $2,953 | $3,454 | $3,576 |
| Total Liabilities And Equity | $3,243 | $4,620 | $5,010 | $4,224 | $4,572 |